Cantex to Present at Upcoming Investor Conferences

12:45 EDT 14 Mar 2018 | BioMedReports - Blog

Dr. Marcus will present Cantex's rapidly advancing drug development pipeline, highlighted by CX-01 and Dicopp™. CX-01 is currently being evaluated in Phase II clinical trials


Original Article: Cantex to Present at Upcoming Investor Conferences


More From BioPortfolio on "Cantex to Present at Upcoming Investor Conferences"

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...